Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16550
Corporate User License Price USD 750
Corporate User License Price INR 49650
Site License Price USD 500
Site License Price INR 33100
Request a Quote

Report Title

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile



Executive Summary

Summary

ULURU Inc (ULURU) is a pharmaceutical company that develops and commercializes wound care and muco-adhesive film products. The company offers products such as Altrazeal, Apthasol, OraDisc W, and others. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU's Apthasol is used for treating aphthous ulcers in people with normal immune systems. The company's OraDisc is a polymer solid dosage form used to deliver amlexanox to the mucosal tissue. It also research and develops Nanoflex technology which is designed for optimizing the wound bed environment and accelerate healing. ULURU is headquartered in Addison, Texas, the US.

ULURU Inc (ULUR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ULURU Inc, Pharmaceuticals & Healthcare, Deal Details 12

Partnerships 12

ULURU Partners with Saraya 12

Licensing Agreements 12

Uluru Expands Licensing Agreement with Altrazeal 12

Uluru Expands Licensing Agreement With Altrazeal 13

Uluru Expands Licensing Agreement With Altrazeal 14

ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 14

ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 15

ULURU Expands Licensing Agreement With Melmed For Altrazeal 16

Equity Offering 17

Uluru Raises USD5 Million in Private Placement of Shares 17

Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 18

Uluru to Raise USD1.6 Million in Private Placement of Shares 19

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 20

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 21

Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 21

ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 23

Uluru Completes Private Placement Of Preferred Shares For US$1 Million 24

ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 25

Debt Offering 27

Uluru Raises USD0.5 Million in Second Tranche of Private Placement of Note 27

Uluru Raises USD0.5 Million in Private Placement of 12.5% Note 28

Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 28

ULURU Inc-Key Competitors 30

Key Employees 31

Locations And Subsidiaries 32

Head Office 32

Other Locations & Subsidiaries 32

Recent Developments 33

Financial Announcements 33

Nov 14, 2016: ULURU Reports Financial Results For Third Quarter 2016 33

Aug 16, 2016: ULURU Reports Financial Results For Second Quarter 2016 35

May 17, 2016: ULURU Reports Financial Results For First Quarter 2016 39

Mar 31, 2016: ULURU Reports Financial Results For Fourth Quarter And Year Ending December 31, 2015 41

Government and Public Interest 44

Feb 22, 2016: ULURU Provides Update On Recent Business Activities-February 2016 44

Other Significant Developments 46

Feb 22, 2016: ULURU Provides Update On Recent Business Activities 46

Appendix 48

Methodology 48

About GlobalData 48

Contact Us 48

Disclaimer 48

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

List of Tables

ULURU Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

ULURU Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

ULURU Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

ULURU Inc, Deals By Therapy Area, 2011 to YTD 2017 9

ULURU Inc, Medical Devices Deals, 2011 to YTD 2017 10

ULURU Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11

ULURU Partners with Saraya 12

Uluru Expands Licensing Agreement with Altrazeal 12

Uluru Expands Licensing Agreement With Altrazeal 13

Uluru Expands Licensing Agreement With Altrazeal 14

ULURU Enters Into Licensing Agreement With Melmed Holdings For Altrazeal 14

ULURU Expands Licensing Agreement With Melmed For Altrazeal To Middle East And North Africa 15

ULURU Expands Licensing Agreement With Melmed For Altrazeal 16

Uluru Raises USD5 Million in Private Placement of Shares 17

Uluru to Raise USD1.8 Million in Private Placement of Shares and Warrants 18

Uluru to Raise USD1.6 Million in Private Placement of Shares 19

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.09 Million 20

Uluru Completes First Tranche Of Private Placement Of Shares For US$0.4 Million 21

Uluru Increases Size Of Private Placement Of Shares For US$2.4 Million 21

ULURU Files Registration Statement For Private Placement Of Shares For US$1 Million 23

Uluru Completes Private Placement Of Preferred Shares For US$1 Million 24

ULURU Completes Registered Direct Offering Of Its Common Stock For US$0.5 Million 25

Uluru Raises USD0.5 Million in Second Tranche of Private Placement of Note 27

Uluru Raises USD0.5 Million in Private Placement of 12.5% Note 28

Uluru Completes First Tranche Of Private Placement Of 8% Secured Convertible Notes For US$0.7 Million 28

ULURU Inc, Key Competitors 30

ULURU Inc, Key Employees 31

ULURU Inc, Subsidiaries 32

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

ULURU Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand